• Dr. Athalye brings over 25 years of experience working across the global pharmaceutical industry.
• Most recently, he served as Chief Development Officer at Biocon Biologics, representing a member of their Executive Committee and leading Global R&D, CDMA, and Safety and Regulatory Affairs.
• He had oversight of Clinical Development, Regulatory Strategy, Medical Affairs, Clinical Operations, Medical Writing, Statistics, Drug Safety & Pharmacovigilance, Clinical Quality & Compliance, Value-based Contracting, Digital Therapeutics, Licensing and Partnerships, and Market Access.
• Biocon Biologics – Chief Development Officer leading global R&D, CDMA, Safety, and Regulatory Affairs.
• Boehringer Ingelheim – Vice President and Global Head, Clinical Development and Medical Affairs, Biosimilars Unit.
• Novartis – Clinical Franchise Lead (Respiratory and Neuroscience/Ophthalmics).
• Schering-Plough Research Institute – Clinical Research Scientist.
• MBBS in Medicine from Bharati Vidyapeeth.
• MS in Clinical Pharmacology from The University of Toledo.
• MBA in BioPharma Innovation from Rutgers University.
.png)
